Vital Signs Blood Pressure Trial
Launched by STANFORD UNIVERSITY · Feb 14, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Vital Signs Blood Pressure Trial is a research study aimed at creating a new device to monitor blood pressure continuously and without the need for invasive procedures. The study will collect important health information, such as blood pressure readings, heart activity through an electrocardiogram (ECG), and blood flow signals using a method called photoplethysmography (PPG). This data will help develop a reliable way to track blood pressure over time, which is crucial for managing conditions like hypertension and other heart-related diseases.
To participate in this trial, you need to be between 18 and 64 years old and have a body mass index (BMI) between 20 and 35, which is a measure of body weight relative to height. Unfortunately, those who are pregnant or outside of this age and BMI range will not be eligible. If you decide to join, you will be helping researchers gather valuable information that could lead to better blood pressure monitoring methods for everyone. Please note that the trial is not yet recruiting participants, so keep an eye out for updates if you are interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>17 and \<65 years
- • BMI \>20 and \<35
- Exclusion Criteria:
- • Age \<18 or \>64
- • BMI \<20 or \>35
- • Pregnancy
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported